← FDA Drug Approvals (Drugs@FDA)

ABACAVIR SULFATE AND LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-11-15

Drug application

FDA Application #

ANDA090159

Application type

Abbreviated New Drug Application (Generic)

Brand name

ABACAVIR SULFATE AND LAMIVUDINE

Generic name

ABACAVIR AND LAMIVUDINE

Active ingredients

ABACAVIR SULFATE; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Aurobindo Pharma Limited

First approval

2018-11-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown